The role of thyroid hormone nuclear receptors in the heart: evidence from pharmacological approaches

Open Access
Authors
  • W.M. Wiersinga
Publication date 2010
Journal Heart Failure Reviews
Volume | Issue number 15 | 2
Pages (from-to) 121-124
Organisations
  • Faculty of Medicine (AMC-UvA)
Abstract
This review evaluates the hypothesis that the cardiac effects of amiodarone can be explained-at least partly-by the induction of a local 'hypothyroid-like condition' in the heart. Evidence supporting the hypothesis comprises the observation that amiodarone exerts an inhibitory effect on the binding of T3 to thyroid hormone receptors (TR) alpha-1 and beta-1 in vitro, and on the expression of particular T3-dependent genes in vivo. In the heart, amiodarone decreases heart rate and alpha myosin heavy chain expression (mediated via TR alpha-1), and increases sarcoplasmic reticulum calcium-activated ATPase and beta myosin heavy chain expression (mediated via TR beta-1). Recent data show a significant similarity in expression profiles of 8,435 genes in the heart of hypothyroid and amiodarone-treated animals, although similarities do not always exist in transcripts of ion channel genes. Induction of a hypothyroid cardiac phenotype by amiodarone may be advantageous by decreasing energy demands and increasing energy availability
Document type Article
Published at
https://doi.org/10.1007/s10741-008-9131-9 (Final published version)
Downloads
342104.pdf (Final published version)
Permalink to this page
Back